首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1550539

疫苗市場：按類型、技術、適應症、給藥途徑及地區分類

Vaccines Market, By Type, By Technology, By Disease Indication, By Route of Administration, By Geography

出版日期: 2024年08月16日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球疫苗市場規模為771.2億美元，預計2031年將達1,161億美元，2024年至2031年複合年成長率為6%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	771.2億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測 2024-2031 年複合年成長率：	6.00%	2031年價值預測	1161億美元

圖：2024 年按地區分類的疫苗市場佔有率(%)

近年來，由於各種感染疾病的蔓延和疫苗製造技術的進步，全球疫苗市場經歷了穩定成長。疫苗有助於增強對某些疾病的免疫力，使高風險族群免受危險感染疾病的危及生命的影響。免疫意識的提高，特別是在開發中國家，正在推動全球對先進且負擔得起的疫苗的需求。此外，主要製造商推出組合疫苗有助於提高疫苗接種率並減輕醫療資源的壓力。政府和國際組織對免疫計劃的持續支持預計將在預測期內推動全球疫苗市場的成長。

市場動態：

全球疫苗市場主要由感染疾病率上升、疫苗製造技術進步以及政府對免疫計劃的日益關注所推動。據世界衛生組織 (WHO) 稱，疫苗接種每年可預防 2 至 300 萬人死亡。針對某些疾病的強制性疫苗接種以及全球消除疾病的努力也推動了市場的成長。然而，新疫苗研發伴隨的研發成本飆升、監管部門的嚴格核准以及因錯誤訊息而猶豫不決等因素，是阻礙疫苗廣泛使用的因素。同時，無需冷藏即可承受高溫的熱穩定疫苗、可針對突變病毒提供保護的細胞疫苗技術以及提高低收入和中等收入國家疫苗接種率的舉措的開發將在未來繼續成長。豐厚的機會。

本研究的主要特點

本報告對全球疫苗市場進行了詳細分析，並呈現了以2022年為基準年的預測期（2024-2031）的市場規模和年均成長率。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

該報告根據公司亮點、產品系列、主要業績、財務表現和策略等參數，提供了全球疫苗市場主要企業的概況。

本研究涵蓋的主要企業包括輝瑞、默克、賽諾菲巴斯德、葛蘭素史克 (GSK)、阿斯特捷利康、強生、CSL Limited 和印度血清研究所。

本報告中的見解將幫助負責人和公司經營團隊就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球疫苗市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。

透過分析全球疫苗市場時所使用的各種策略矩陣，將有助於相關人員做出決策。

GlaxoSmithKline plc（GSK）
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Moderna, Inc.
AstraZeneca
Johnson & Johnson
Novavax, Inc.
CSL Limited
Emergent BioSolutions Inc.
Bharat Biotech
Serum Institute of India
BioNTech SE
Takeda Pharmaceutical Company
Sinovac Biotech Ltd.
Sinopharm（China National Pharmaceutical Group）
Vaxart, Inc.
Inovio Pharmaceuticals, Inc.
Valneva SE
Vaccitech plc

第11章分析師建議

命運之輪
分析師觀點
一致的機會圖

第12章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI4914

The Global Vaccines Market is estimated to be valued at USD 77.12 Billion in 2024 and is expected to reach USD 116.10 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 77.12 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	6.00%	2031 Value Projection:	US$ 116.10 Bn

Figure. Vaccines Market Share (%), By Region 2024

The global vaccines market has been witnessing steady growth over the past few years due to the rising prevalence of various infectious diseases and technological advancements in vaccine production. Vaccines aid in building immunity against specific diseases and allow populations at risk to be protected from the life-threatening effects of dangerous infections. Growing awareness about immunization, especially in developing nations is propelling the demand for advanced and affordable vaccines globally. Furthermore, the introduction of combination vaccines by major manufacturers is encouraging higher vaccination rates and reducing the burden on healthcare resources. Continued support from governments and international organizations towards immunization programs is expected to drive the global vaccines market growth during the forecast period.

Market Dynamics:

The global vaccines market is primarily driven by the rising incidence of infectious diseases, technological advancements in vaccine production, and growing focus on immunization programs by governments. According to the World Health Organization (WHO), immunization averts an estimated 2-3 million deaths annually. Mandates on vaccination of certain diseases and worldwide efforts towards disease eradication also provide momentum to market growth. However, high R&D costs associated with new vaccine development, stringent regulatory approvals, and vaccine hesitancy due to misinformation are some of the factors hindering the widespread adoption of vaccines. On the other hand, development of thermostable vaccines that can withstand high temperatures without refrigeration, cell-based vaccine technologies offering protection against mutating viruses, and initiatives to drive vaccine uptake in low and middle-income countries are expected to unlock lucrative opportunities for players in the coming years.

Key features of the study:

This report provides in-depth analysis of the global vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Merck, Sanofi Pasteur, GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, CSL Limited, and Serum Institute of India

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaccines market.

Detailed Segmentation-

By Type Insights (Revenue, USD Bn, 2019 - 2031)
- Monovalent Vaccines
- Mulitvalent Vaccines
By Technology Insights (Revenue, USD Bn, 2019 - 2031)
- Conjugate Vaccines
- Recombinant Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Other Vaccine Technologies
By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
- Tablets/Capsules
- Liquids
- Creams
- Gels
- Others
By Disease Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Pneumococcal Disease
- Influenza
- Combination Vaccines
- HPV
- Meningococcal Disease
- Herpes Zoster
- Rotavirus
- MMR
- Varicella
- Hepatitis
- DTP
- Polio
- RSV
- Other Disease Indications
By Route Of Administration: Insights (Revenue, USD Bn, 2019 - 2031)
- Intramuscular
- Subcutaneous
- Oral
- Intranasal
By Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline plc (GSK)
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Moderna, Inc.
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- CSL Limited
- Emergent BioSolutions Inc.
- Bharat Biotech
- Serum Institute of India
- BioNTech SE
- Takeda Pharmaceutical Company
- Sinovac Biotech Ltd.
- Sinopharm (China National Pharmaceutical Group)
- Vaxart, Inc.
- Inovio Pharmaceuticals, Inc.
- Valneva SE
- Vaccitech plc

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Vaccines Market, By Type
- Global Vaccines Market, By Technology
- Global Vaccines Market, By Dosage Form
- Global Vaccines Market, By Disease Indication
- Global Vaccines Market, By Route of Administration
- Global Vaccines Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Vaccines Market, By Type, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Monovalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Multivalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Vaccines Market, By Technology, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inactivated and Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other Vaccine Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Vaccines Market, By Dosage Form, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Tablets/Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liquids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Vaccines Market, By Disease Indication, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Pneumococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Combination Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
HPV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Meningococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Herpes Zoster
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Rotavirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
MMR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Varicella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
DTP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Polio
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
RSV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other Disease Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Vaccines Market, By Route of Administration, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Vaccines Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
South Africa
North Africa
Central Africa

10. COMPETITIVE LANDSCAPE

GlaxoSmithKline plc (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Moderna, Inc.
AstraZeneca
Johnson & Johnson
Novavax, Inc.
CSL Limited
Emergent BioSolutions Inc.
Bharat Biotech
Serum Institute of India
BioNTech SE
Takeda Pharmaceutical Company
Sinovac Biotech Ltd.
Sinopharm (China National Pharmaceutical Group)
Vaxart, Inc.
Inovio Pharmaceuticals, Inc.
Valneva SE
Vaccitech plc